Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Faculty Opinions recommendation of Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5232959.5173058 ◽

2010 ◽

Author(s):

Jacques Bernier

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Advanced Head ◽

Epidermal Growth ◽

MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells

Cancer Research ◽

10.1158/0008-5472.can-14-2061 ◽

2015 ◽

Vol 75 (8) ◽

pp. 1657-1667 ◽

Cited By ~ 12

Author(s):

Adam T. Koch ◽

Laurie Love-Homan ◽

Madelyn Espinosa-Cotton ◽

Aditya Stanam ◽

Andrean L. Simons

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Epidermal Growth

Epidermal growth factor receptor inhibitor induces Interleukin-6 via NADPH oxidase enzymes in head and neck cancer cells

10.17077/etd.t0bey3zr ◽

2012 ◽

Author(s):

Elise Virginia May Fletcher

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Nadph Oxidase ◽

Cancer Cells ◽

Interleukin 6 ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Abstract 5505: MyD88-dependent signaling decreases the anti-tumor efficacy of epidermal growth factor receptor inhibition in head and neck cancer cells

10.1158/1538-7445.am2015-5505 ◽

2015 ◽

Author(s):

Andrean L. Simons-Burnett ◽

Adam T. Koch ◽

Laurie Love-Homan ◽

Aditya Stanam

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Epidermal Growth

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-2582 ◽

2007 ◽

Vol 13 (8) ◽

pp. 2512-2518 ◽

Cited By ~ 42

Author(s):

Felix Y. Feng ◽

Carlos A. Lopez ◽

Daniel P. Normolle ◽

Sooryanarayana Varambally ◽

Xiaoxin Li ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Growth Factor Receptor ◽

Concurrent Radiochemotherapy ◽

Epidermal Growth ◽

Disseminated Mycobacterium chelonae Infection in a Patient Receiving an Epidermal Growth Factor Receptor Inhibitor for Advanced Head and Neck Cancer

Journal of Clinical Microbiology ◽

10.1128/jcm.05399-11 ◽

2011 ◽

Vol 50 (1) ◽

pp. 194-195 ◽

Cited By ~ 6

Author(s):

Charles M. Bark ◽

Rana S. Traboulsi ◽

Kord Honda ◽

Autumn M. Starnes ◽

Michael R. Jacobs ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Growth Factor Receptor ◽

Advanced Head ◽

Mycobacterium Chelonae ◽

Epidermal Growth ◽

Combined RT and epidermal growth factor receptor inhibitor monoclonal antibody-MoAb-EGFr treatment of head and neck cancer (HNC): Radiobiological model for FAMOSO

Physica Medica ◽

10.1016/j.ejmp.2016.01.055 ◽

2016 ◽

Vol 32 ◽

pp. 15-16

Author(s):

M. Cremonesi ◽

D. Alterio ◽

C. Garibaldi ◽

A.M. Ferrari ◽

F. Botta ◽

...

Keyword(s):

Monoclonal Antibody ◽

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Growth Factor Receptor ◽

Radiobiological Model ◽

Epidermal Growth ◽

PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells

Molecular Cancer Research ◽

10.1158/1541-7786.mcr-19-0592 ◽

2020 ◽

Vol 18 (9) ◽

pp. 1392-1401

Author(s):

Michael I. Dougherty ◽

Christine E. Lehman ◽

Adam Spencer ◽

Rolando E. Mendez ◽

Abel P. David ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Induced Resistance ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Epidermal Growth

Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7

PLoS ONE ◽

10.1371/journal.pone.0047067 ◽

2012 ◽

Vol 7 (10) ◽

pp. e47067 ◽

Cited By ~ 51

Author(s):

Felicity C. Kalinowski ◽

Keith M. Giles ◽

Patrick A. Candy ◽

Alishum Ali ◽

Clarissa Ganda ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer

Seminars in Oncology ◽

10.1053/sonc.2002.35644 ◽

2002 ◽

Vol 29 (5 Suppl 14) ◽

pp. 18-30 ◽

Cited By ~ 58

Author(s):

Roy S. Herbst ◽

Waun Ki Hong

Keyword(s):

Monoclonal Antibody ◽

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Monoclonal Antibody